BSX
Boston Scientific Corporation
NYSE · Healthcare · Medical - Devices · US
$47.69
+1.57%Margins
Gross margin
71.2%
EBITDA margin
27.1%
EBIT margin
21.5%
Net margin
17.5%
FCF margin
17.3%
14.7%
Return on equity
8.1%
Return on assets
12.0%
Return on invested capital
0.47x
Asset turnover
$4.5B
Cash from operations
$0.37
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026